How Long Does Ipamorelin Stay in Your System? Half-Life Data
The quick version
How long does ipamorelin stay in your system? The cleanest number comes from healthy human volunteers: a terminal half-life of about 2 hours after IV dosing [2]. A half-life is the time it takes for the amount in your blood to fall by half — so after roughly 2 hours, half is gone; after about four to five half-lives (around 8–10 hours), it is effectively cleared. The growth-hormone pulse it triggers is even quicker, arriving as a single peak about 40 minutes after dosing [2]. Two caveats: the drug itself leaving the blood is not the same as its downstream effects fading, and detection in anti-doping testing can outlast the parent compound. No doses appear here, and nothing on this page is medical advice.
The human half-life number
The answer to how long does ipamorelin stay in your system rests on the population PK/PD study in healthy male volunteers (n=8 per dose level), given five 15-minute IV infusions from 4.21 to 140.45 nmol/kg [2]. Kinetics were linear and dose-proportional, with a terminal half-life of approximately 2 hours, clearance of 0.078 L/h/kg, and a steady-state volume of distribution of 0.22 L/kg [2]. "Terminal half-life" describes the slow elimination phase — the tail of the curve — so it is the figure that governs how long a measurable amount lingers. At ~2 hours, ipamorelin is a short-residence peptide.
From dose to effect: the 40-minute pulse
The blood half-life and the effect timing are two different clocks. After dosing, the growth-hormone response appears as a single discrete pulse peaking around 0.67 h — roughly 40 minutes — after administration [2]. That is faster than the 2-hour terminal half-life because the GH pulse is the body's response to the peptide, not the peptide's own concentration. The practical reading: the hormonal event is brief and front-loaded, while traces of the peptide decline over the following hours [2].
How route changes the timeline
All the human half-life data come from IV dosing [2]. Other routes shift the kinetics. In rats, plasma clearance is roughly 5-fold lower than GHRP-6 [1]. Subcutaneous administration — the dominant route in community use — has no published human PK characterization at all, so its real-world time-in-system is genuinely uncharacterized [3]. Intranasal rodent data show ~20% bioavailability. And oral kinetics apply only to engineered analogs like NN703 (plasma half-life 4.1 ± 0.4 h, ~30% oral bioavailability in dogs) [7], not to ipamorelin itself, which is not orally bioavailable.
Detection in sport lasts longer than the half-life
"Out of your system" means two different things. Pharmacologically, ipamorelin clears within hours of an IV dose [2]. For anti-doping, the relevant question is detectability: ipamorelin and other growth-hormone secretagogues are prohibited in sport at all times under WADA category S2, and accredited laboratories have established urine-detection methods for them. Detection windows for peptide secretagogues commonly outlast the parent compound's plasma half-life, so a short half-life does not imply a short detection window. This is a compliance fact, not dosing guidance.
What the half-life does not tell you
A ~2-hour half-life is a clean number, but it has limits. It is acute, single-dose, IV, and from a small healthy-volunteer study [2]; it says nothing about steady-state accumulation, subcutaneous kinetics, or what repeated dosing over weeks does. It also says nothing about safety duration — because no long-term human safety study of ipamorelin exists [3]. So the half-life answers "how fast does one IV dose clear" precisely, and leaves "what happens with sustained real-world use" unanswered.